-
Product Insights
NewCytokine Release Syndrome (Cytokine Storm) – Drugs In Development, 2024
Empower your strategies with our Cytokine Release Syndrome (Cytokine Storm) – Drugs In Development, 2024 report and make more profitable business decisions. Cytokine release syndrome (CRS) is a systemic inflammatory response, potentially life-threatening and triggered by various factors like infections and specific drugs. It can occur following the administration of natural and bispecific antibodies, as well as adoptive T-cell therapies for cancer. CRS is characterized by elevated levels of cytokines, including interleukin (IL)-6 and interferon γ. Tocilizumab, an anti-IL-6 receptor antibody,...
-
Product Insights
NewHemolytic Uremic Syndrome – Drugs In Development, 2024
Empower your strategies with our Hemolytic Uremic Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Hemolytic uremic syndrome (HUS) is a rare but serious condition that affects the blood vessels and kidneys. It is caused by the damage and inflammation of small blood vessels, which leads to the formation of blood clots that block the flow of blood and oxygen to the organs. HUS can result in anemia, low platelet count, and kidney failure. The most...
-
Product Insights
NewAtypical Hemolytic Uremic Syndrome (Nondiarrhea – Associated Hemolytic Uremic Syndrome) – Drugs In Development, 2024
Empower your strategies with our Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Atypical hemolytic uremic syndrome is a disease that primarily affects kidney function. This condition, which can occur at any age, causes abnormal blood clots (thrombi) to form in the small blood vessels in the kidneys. Symptoms include vomiting, abdominal pain, pale skin tone, fatigue and irritability, blood in the urine, and confusion. The Atypical...
-
Product Insights
NewHemoglobinuria – Drugs In Development, 2024
Empower your strategies with our Hemoglobinuria – Drugs In Development, 2024 report and make more profitable business decisions. Hemoglobinuria is a condition characterized by the presence of free hemoglobin in the urine. Hemoglobin is the protein in red blood cells responsible for transporting oxygen throughout the body. When red blood cells break down, the released hemoglobin can be filtered by the kidneys and appear in the urine, giving it a red or brown color. Hemoglobinuria can result from various conditions, including...
-
Product Insights
NewParoxysmal Nocturnal Hemoglobinuria – Drugs In Development, 2024
Empower your strategies with our Paroxysmal Nocturnal Hemoglobinuria – Drugs In Development, 2024 report and make more profitable business decisions. Paroxysmal nocturnal hemoglobinuria is a rare disease in which red blood cells break down earlier than normal. Symptoms include abdominal pain, back pain, dark urine, easy bruising or bleeding, headache, and shortness of breath. The predisposing factors include age, obesity, and hormone therapy. Treatment includes surgery, chemotherapy, and radiation therapy. The Paroxysmal Nocturnal Hemoglobinuria drugs in development market research report provide...
-
Product Insights
NewMacular Edema – Drugs In Development, 2024
Empower your strategies with our Macular Edema – Drugs In Development, 2024 report and make more profitable business decisions. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the...
-
Product Insights
NewRetinopathy – Drugs In Development, 2024
Empower your strategies with our Retinopathy – Drugs In Development, 2024 report and make more profitable business decisions. Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of a systemic disease such as diabetes or hypertension. The Retinopathy...
-
Product Insights
NewTransitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024
Empower your strategies with our Transitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Transitional cell carcinoma (TCC), also known asurothelial cell carcinoma, is a type of cancer that primarily affects the transitional epithelial cells lining the urinary tract, including the bladder, ureters, and renal pelvis. It is the most common form of bladder cancer. TCC arises when these cells undergo malignant changes, often due to exposure to carcinogens like tobacco or...
-
Product Insights
NewRecurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024
Empower your strategies with our Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent glioblastoma multiforme (GBM) refers to the return of aggressive brain tumors known as glioblastomas after initial treatment. GBM is the most malignant type of glioma, characterized by rapid growth and infiltrative behavior. Despite aggressive therapies like surgery, radiation, and chemotherapy, GBM often recurs due to its invasive nature and resistance to treatment. Management of recurrent GBM poses significant challenges....
-
Product Insights
NewOsteoporosis – Drugs In Development, 2024
Empower your strategies with our Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, and a bone fracture that occurs much more easily than...